Valuing personalized medicine: willingness to pay for genetic testing for colorectal cancer risk

Author： Van Bebber Stephanie L   Liang Su-Ying   Phillips Kathryn A   Marshall Deborah   Walsh Judith   Kulin Nathalie  

Publisher： Future Medicine

ISSN： 1741-0541

Source： Personalized Medicine, Vol.4, Iss.3, 2007-08, pp. : 341-350

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metabolomic profiling in colorectal cancer: opportunities for personalized medicine

By Zheng Xiaojiao   Xie Guoxiang   Jia Wei  

Personalized Medicine, Vol. 10, Iss. 7, 2013-09 ,pp. : 741-755

Future Medicine

Access to resources Recommend Favorite

Risk-based and diagnostics-linked personalized medicine for cancer

By Srivastava Sudhir   Wagner Paul D  

Personalized Medicine, Vol. 4, Iss. 1, 2007-02 ,pp. : 33-43

Future Medicine

Access to resources Recommend Favorite

Genetic testing and implications for personalized medicine: changes in public and healthcare professional perspectives

By Henneman Lidewij   van El Carla G   Cornel Martina C  

Personalized Medicine, Vol. 10, Iss. 3, 2013-05 ,pp. : 217-219

Future Medicine

Access to resources Recommend Favorite

Healthcare impact of personalized medicine using genetic testing: an exploratory analysis for warfarin

By McWilliam Andrew   Lutter Randall   Nardinelli Clark  

Personalized Medicine, Vol. 5, Iss. 3, 2008-05 ,pp. : 279-284

Future Medicine

Access to resources Recommend Favorite

Hereditary colorectal cancer syndromes and genetic testing

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 111, Iss. 1, 2015-01 ,pp. : 103-111

John Wiley & Sons Inc

Access to resources Recommend Favorite